Constellation Software Inc. Announces Release Date for Third Quarter Results
October 20, 2025 17:12 ET Â | Source: Constellation Software Inc. TORONTO, Oct.…
Topicus.com Inc. Announces Release Date for Third Quarter Results
October 20, 2025 17:11 ET Â | Source: Topicus.com Inc. TORONTO, Oct. 20,…
ServiceTrade Launches Grow Your Own Technician Workforce Program with VSC Fire & Security and Durham Tech
$5,000 grant will underwrite a new apprentice hire and training; the program…
WePlay x Care Bears Halloween Carnival Party Officially Kicks Off!
WASHINGTON, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As Halloween night falls, WePlay teams…
Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
PSMAddition data show Novartis Pluvicto delays progression to end-stage prostate cancer
Basel, October 19, 2025 – Novartis today presents new Pluvictoâ„¢ (lutetium (177Lu)…
Deleion Capital Launches Innovative Digital Asset Management Plan for BTC to Empower Modern Investors
Miami, Florida, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Deleion Capital, a leading…
Free Welcome Bonus No Deposit Required Real Money Online Casino By Cafe Casino
New York City, NY, Oct. 18, 2025 (GLOBE NEWSWIRE) -- U.S. iGaming…
Precede Biosciences Presents New ESMO 2025 Data Demonstrating Its Liquid Biopsy Platforms Ability to Resolve Target Expression and Molecular Subtypes in Small Cell Lung Cancer
Small cell lung cancer (SCLC) accounts for 15% of all lung cancers…
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
Media Release COPENHAGEN, Denmark; October 18, 2025 Updated data from the Phase…